316,400 Shares in Lemonade, Inc. (NYSE:LMND) Purchased by Analyst IMS Investment Management Services Ltd.

Analyst IMS Investment Management Services Ltd. acquired a new position in Lemonade, Inc. (NYSE:LMND - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 316,400 shares of the company's stock, valued at approximately $9,944,000. Lemonade accounts for approximately 0.4% of Analyst IMS Investment Management Services Ltd.'s investment portfolio, making the stock its 24th biggest position. Analyst IMS Investment Management Services Ltd. owned 0.43% of Lemonade as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its position in Lemonade by 2,627.9% in the 4th quarter. JPMorgan Chase & Co. now owns 1,349,356 shares of the company's stock valued at $49,494,000 after buying an additional 1,299,891 shares during the period. Two Sigma Investments LP purchased a new position in shares of Lemonade during the fourth quarter worth approximately $22,066,000. Voloridge Investment Management LLC bought a new stake in shares of Lemonade during the fourth quarter valued at approximately $21,310,000. Two Sigma Advisers LP purchased a new stake in shares of Lemonade in the fourth quarter valued at approximately $15,412,000. Finally, Connor Clark & Lunn Investment Management Ltd. grew its stake in Lemonade by 402.5% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 275,161 shares of the company's stock worth $10,093,000 after purchasing an additional 220,399 shares in the last quarter. 80.30% of the stock is owned by hedge funds and other institutional investors.

Lemonade Stock Up 6.8%

Shares of Lemonade stock traded up $2.57 during trading on Thursday, reaching $40.44. The company's stock had a trading volume of 3,491,353 shares, compared to its average volume of 2,036,956. Lemonade, Inc. has a 1-year low of $14.90 and a 1-year high of $53.85. The company has a 50-day simple moving average of $32.57 and a two-hundred day simple moving average of $34.48. The company has a market cap of $2.96 billion, a price-to-earnings ratio of -13.30 and a beta of 2.14.

Lemonade (NYSE:LMND - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.86) EPS for the quarter, missing analysts' consensus estimates of ($0.84) by ($0.02). Lemonade had a negative net margin of 38.90% and a negative return on equity of 36.72%. The firm's revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.67) earnings per share. As a group, analysts anticipate that Lemonade, Inc. will post -3.03 earnings per share for the current year.

Insider Buying and Selling

In other Lemonade news, insider John Sheldon Peters sold 1,494 shares of Lemonade stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $35.25, for a total transaction of $52,663.50. Following the completion of the sale, the insider now owns 106,115 shares of the company's stock, valued at approximately $3,740,553.75. The trade was a 1.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Softbank Group Capital Ltd sold 42,160 shares of the firm's stock in a transaction dated Wednesday, March 26th. The stock was sold at an average price of $37.22, for a total value of $1,569,195.20. Following the completion of the transaction, the insider now owns 10,452,476 shares of the company's stock, valued at approximately $389,041,156.72. The trade was a 0.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 2,744,737 shares of company stock worth $87,411,365 in the last three months. Corporate insiders own 14.70% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on LMND. Morgan Stanley lowered shares of Lemonade from an "equal weight" rating to an "underweight" rating and lowered their price objective for the stock from $35.00 to $24.00 in a research note on Tuesday, April 8th. Keefe, Bruyette & Woods lowered their price target on shares of Lemonade from $25.00 to $22.00 and set an "underperform" rating for the company in a research report on Tuesday, April 22nd. Finally, Piper Sandler dropped their price objective on shares of Lemonade from $44.00 to $34.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Four investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $28.17.

Lemonade Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.